Calls For COVID Patent Waivers Persist As Pooling Initiatives Plough Ahead

Patents On COVID-19 Therapeutics Have Been Accused Of Impeding International Access

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.